Navigation Links
Women Less Likely to Control LDL Cholesterol Levels Than Men

A new study has found that women are significantly less likely than men to have their LDL cholesterol controlled to recommended levels .

Elevated LDL cholesterol is an important modifiable risk factor for cardiovascular disease, the leading single cause of death for both women and men.

The study titled 'Improving the Quality of Care for Cardiovascular Disease: Using National Managed Care Performance Data to Investigate Gender Differences in HEDIS Measures Related to Heart Disease', was conducted by a team of researchers including Margaret E. O'Kane and Ileana L. Pina at the National Committee for Quality Assurance (NCQA).

As part of the study, researchers analysed data from a national sample of 46 commercial managed care plans and 148 Medicare plans across 11 HEDIS(r) measures of care for cardiovascular conditions and diabetes.

Researchers found that the study showed equal or better outcomes for women on most dimensions of care except that of cholesterol control, where significant disparities existed between men and women.

The study also investigated disparities in care owing to race and income level, and found significant gaps in care.

The findings suggested that women and their health care providers underestimate risk for high cholesterol and heart disease, leading to poorer cholesterol control among women. The high cost of medications may also be secondary factor.

"This study highlights the importance of not just knowing your health, but also taking an active role in your care. The data show that we've got our work cut out for us in terms of raising awareness among both physicians and patients," E. O'Kane said.

"Women must know their risk for heart disease and how to manage it. These study findings show an opportunity to improve patient care for women and a reason to encourage women to consider seriously how to manage their risk factors, such as elev
'"/>




Page: 1 2

Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5New iPhone Application for Anesthesiologists 51079 1New iPhone Application for Anesthesiologists 51079 2BullMarket com Updates Outlook on Healthcare IT Stocks 51074 1BullMarket com Updates Outlook on Healthcare IT Stocks 51074 2Health Caregivers and Allies to Rally 5 p m Weds in Fremont 51070 1Health Caregivers and Allies to Rally 5 p m Weds in Fremont 51070 2